These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


435 related items for PubMed ID: 14557356

  • 1. Infarct remodeling after intracoronary progenitor cell treatment in patients with acute myocardial infarction (TOPCARE-AMI): mechanistic insights from serial contrast-enhanced magnetic resonance imaging.
    Britten MB, Abolmaali ND, Assmus B, Lehmann R, Honold J, Schmitt J, Vogl TJ, Martin H, Schächinger V, Dimmeler S, Zeiher AM.
    Circulation; 2003 Nov 04; 108(18):2212-8. PubMed ID: 14557356
    [Abstract] [Full Text] [Related]

  • 2. Intracoronary administration of bone marrow-derived progenitor cells improves left ventricular function in patients at risk for adverse remodeling after acute ST-segment elevation myocardial infarction: results of the Reinfusion of Enriched Progenitor cells And Infarct Remodeling in Acute Myocardial Infarction study (REPAIR-AMI) cardiac magnetic resonance imaging substudy.
    Dill T, Schächinger V, Rolf A, Möllmann S, Thiele H, Tillmanns H, Assmus B, Dimmeler S, Zeiher AM, Hamm C.
    Am Heart J; 2009 Mar 04; 157(3):541-7. PubMed ID: 19249426
    [Abstract] [Full Text] [Related]

  • 3. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial.
    Schächinger V, Assmus B, Britten MB, Honold J, Lehmann R, Teupe C, Abolmaali ND, Vogl TJ, Hofmann WK, Martin H, Dimmeler S, Zeiher AM.
    J Am Coll Cardiol; 2004 Oct 19; 44(8):1690-9. PubMed ID: 15489105
    [Abstract] [Full Text] [Related]

  • 4. Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial.
    Meyer GP, Wollert KC, Lotz J, Steffens J, Lippolt P, Fichtner S, Hecker H, Schaefer A, Arseniev L, Hertenstein B, Ganser A, Drexler H.
    Circulation; 2006 Mar 14; 113(10):1287-94. PubMed ID: 16520413
    [Abstract] [Full Text] [Related]

  • 5. Differential effect of intracoronary infusion of mobilized peripheral blood stem cells by granulocyte colony-stimulating factor on left ventricular function and remodeling in patients with acute myocardial infarction versus old myocardial infarction: the MAGIC Cell-3-DES randomized, controlled trial.
    Kang HJ, Lee HY, Na SH, Chang SA, Park KW, Kim HK, Kim SY, Chang HJ, Lee W, Kang WJ, Koo BK, Kim YJ, Lee DS, Sohn DW, Han KS, Oh BH, Park YB, Kim HS.
    Circulation; 2006 Jul 04; 114(1 Suppl):I145-51. PubMed ID: 16820564
    [Abstract] [Full Text] [Related]

  • 6. Restoration of microvascular function in the infarct-related artery by intracoronary transplantation of bone marrow progenitor cells in patients with acute myocardial infarction: the Doppler Substudy of the Reinfusion of Enriched Progenitor Cells and Infarct Remodeling in Acute Myocardial Infarction (REPAIR-AMI) trial.
    Erbs S, Linke A, Schächinger V, Assmus B, Thiele H, Diederich KW, Hoffmann C, Dimmeler S, Tonn T, Hambrecht R, Zeiher AM, Schuler G.
    Circulation; 2007 Jul 24; 116(4):366-74. PubMed ID: 17620510
    [Abstract] [Full Text] [Related]

  • 7. Transcoronary transplantation of progenitor cells after myocardial infarction.
    Assmus B, Honold J, Schächinger V, Britten MB, Fischer-Rasokat U, Lehmann R, Teupe C, Pistorius K, Martin H, Abolmaali ND, Tonn T, Dimmeler S, Zeiher AM.
    N Engl J Med; 2006 Sep 21; 355(12):1222-32. PubMed ID: 16990385
    [Abstract] [Full Text] [Related]

  • 8. Red blood cell contamination of the final cell product impairs the efficacy of autologous bone marrow mononuclear cell therapy.
    Assmus B, Tonn T, Seeger FH, Yoon CH, Leistner D, Klotsche J, Schächinger V, Seifried E, Zeiher AM, Dimmeler S.
    J Am Coll Cardiol; 2010 Mar 30; 55(13):1385-94. PubMed ID: 20338501
    [Abstract] [Full Text] [Related]

  • 9. Mechanisms of improvement of left ventricle remodeling by trans-planting two kinds of autologous bone marrow stem cells in pigs.
    Li SR, Qi XY, Hu FL, Zhang JQ, Wang TH, Dang Y, Meng CL, Liu HL, Li YX, Wu D, Dong J, Xun LY, Gao LH, Jin FC.
    Chin Med J (Engl); 2008 Dec 05; 121(23):2403-9. PubMed ID: 19102957
    [Abstract] [Full Text] [Related]

  • 10. Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI).
    Assmus B, Schächinger V, Teupe C, Britten M, Lehmann R, Döbert N, Grünwald F, Aicher A, Urbich C, Martin H, Hoelzer D, Dimmeler S, Zeiher AM.
    Circulation; 2002 Dec 10; 106(24):3009-17. PubMed ID: 12473544
    [Abstract] [Full Text] [Related]

  • 11. Differential effects of progenitor cell populations on left ventricular remodeling and myocardial neovascularization after myocardial infarction.
    Dubois C, Liu X, Claus P, Marsboom G, Pokreisz P, Vandenwijngaert S, Dépelteau H, Streb W, Chaothawee L, Maes F, Gheysens O, Debyser Z, Gillijns H, Pellens M, Vandendriessche T, Chuah M, Collen D, Verbeken E, Belmans A, Van de Werf F, Bogaert J, Janssens S.
    J Am Coll Cardiol; 2010 May 18; 55(20):2232-43. PubMed ID: 20466204
    [Abstract] [Full Text] [Related]

  • 12. The BALANCE Study: clinical benefit and long-term outcome after intracoronary autologous bone marrow cell transplantation in patients with acute myocardial infarction.
    Yousef M, Schannwell CM, Köstering M, Zeus T, Brehm M, Strauer BE.
    J Am Coll Cardiol; 2009 Jun 16; 53(24):2262-9. PubMed ID: 19520249
    [Abstract] [Full Text] [Related]

  • 13. Clinical outcome 2 years after intracoronary administration of bone marrow-derived progenitor cells in acute myocardial infarction.
    Assmus B, Rolf A, Erbs S, Elsässer A, Haberbosch W, Hambrecht R, Tillmanns H, Yu J, Corti R, Mathey DG, Hamm CW, Süselbeck T, Tonn T, Dimmeler S, Dill T, Zeiher AM, Schächinger V, REPAIR-AMI Investigators.
    Circ Heart Fail; 2010 Jan 16; 3(1):89-96. PubMed ID: 19996415
    [Abstract] [Full Text] [Related]

  • 14. [Effect of persistent microvascular obstruction on post-infarction ventricular remodeling following intracoronary bone-marrow cell transplantation: a contrast-enhanced cardiac magnetic resonance study].
    Villa A, Tejedor-Viñuela P, Sánchez PL, Tapia C, Arnold R, Gómez-Salvador I, García-Frade LJ, Sánchez A, Fernández-Avilés F, San Román JA.
    Rev Esp Cardiol; 2008 Jun 16; 61(6):602-10. PubMed ID: 18570781
    [Abstract] [Full Text] [Related]

  • 15. Administration of intracoronary bone marrow mononuclear cells on chronic myocardial infarction improves diastolic function.
    Yao K, Huang R, Qian J, Cui J, Ge L, Li Y, Zhang F, Shi H, Huang D, Zhang S, Sun A, Zou Y, Ge J.
    Heart; 2008 Sep 16; 94(9):1147-53. PubMed ID: 18381377
    [Abstract] [Full Text] [Related]

  • 16. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction.
    Schächinger V, Erbs S, Elsässer A, Haberbosch W, Hambrecht R, Hölschermann H, Yu J, Corti R, Mathey DG, Hamm CW, Süselbeck T, Assmus B, Tonn T, Dimmeler S, Zeiher AM, REPAIR-AMI Investigators.
    N Engl J Med; 2006 Sep 21; 355(12):1210-21. PubMed ID: 16990384
    [Abstract] [Full Text] [Related]

  • 17. Design and rationale for the Myocardial Stem Cell Administration After Acute Myocardial Infarction (MYSTAR) Study: a multicenter, prospective, randomized, single-blind trial comparing early and late intracoronary or combined (percutaneous intramyocardial and intracoronary) administration of nonselected autologous bone marrow cells to patients after acute myocardial infarction.
    Nyolczas N, Gyöngyösi M, Beran G, Dettke M, Graf S, Sochor H, Christ G, Edes I, Balogh L, Krause KT, Jaquet K, Kuck KH, Benedek I, Hintea T, Kiss R, Préda I, Kotevski V, Pejkov H, Dudek D, Heba G, Sylven C, Charwat S, Jacob R, Maurer G, Lang I, Glogar D.
    Am Heart J; 2007 Feb 21; 153(2):212.e1-7. PubMed ID: 17239678
    [Abstract] [Full Text] [Related]

  • 18. Intracoronary infusion of bone marrow-derived selected CD34+CXCR4+ cells and non-selected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction: results of randomized, multicentre Myocardial Regeneration by Intracoronary Infusion of Selected Population of Stem Cells in Acute Myocardial Infarction (REGENT) Trial.
    Tendera M, Wojakowski W, Ruzyłło W, Chojnowska L, Kepka C, Tracz W, Musiałek P, Piwowarska W, Nessler J, Buszman P, Grajek S, Breborowicz P, Majka M, Ratajczak MZ, REGENT Investigators.
    Eur Heart J; 2009 Jun 21; 30(11):1313-21. PubMed ID: 19208649
    [Abstract] [Full Text] [Related]

  • 19. The clinical study of autologous peripheral blood stem cell transplantation by intracoronary infusion in patients with acute myocardial infarction (AMI).
    Li ZQ, Zhang M, Jing YZ, Zhang WW, Liu Y, Cui LJ, Yuan L, Liu XZ, Yu X, Hu TS.
    Int J Cardiol; 2007 Jan 31; 115(1):52-6. PubMed ID: 16822566
    [Abstract] [Full Text] [Related]

  • 20. Bone-marrow-derived cell transfer after ST-elevation myocardial infarction: lessons from the BOOST trial.
    Drexler H, Meyer GP, Wollert KC.
    Nat Clin Pract Cardiovasc Med; 2006 Mar 31; 3 Suppl 1():S65-8. PubMed ID: 16501634
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 22.